Issues in Genetics
Policy, legal and ethical issues in genetic research
Feature

ASHG/NHGRI Genetics and Public Policy Fellowship application period is closed

Former and current NHGRI/ASHG FellowsThe application period for the 2015-2016 Genetics and Public Policy Fellowship is now closed. The fellowship is designed for genetics professionals with an advanced degree who are early in their careers and interested in the development and implementation of genetics-related health and research policies at a national level. Applications were received until April 24, 2015 and are now being reviewed. Read more


NHGRI updates online resource on informed consent for genomics research

Read moreInformed consent is the basic and primary tool through which investigators communicate with each potential study participant and is vital to ensuring that the research purpose, any risks and possible benefits, or other implications of participation are understood.  NHGRI's online Informed Consent Resource has helped thousands of researchers navigate the informed consent process since 2009.  Now, the ICR has been updated to keep pace with advances in genomics over the past several years. Read more


 

Highlights

NIH Genomic Data Sharing Policy Issued

Globe with genomic data circling around

NIH has issued a position statement on the use of public or private cloud systems for storing and analyzing controlled-access genomic data under the NIH Genomic Data Sharing (GDS) Policy. Read the Position Statement


FDA proposes oversight of laboratory-developed tests

FDA logo The U.S. Food and Drug Administration (FDA) today announced steps it will take to ensure that certain tests used by health care professionals to diagnose and treat patients provide accurate, consistent and reliable results to inform patient care. These steps come at a critical time for genomic, or precision, medicine. As more and more genetic tests are developed and marketed, the public must be able to rely on the accuracy and clinical validity of these tests.
Read the FDA Release
Read a statement from NIH Director Francis Collins


Last Updated: March 30, 2015